Logo

AKUMS DRUGS AND PHARMA L Share Price

NSE: AKUMS
|
Pharmaceuticals
₹ 626.80
-₹10.65 (-1.67%)
1D
Last updated 03 Jul, 2026, 15:43 IST

AKUMS DRUGS AND PHARMA L Share Price Today

As of 5 Jul 2026, AKUMS DRUGS AND PHARMA L share price is ₹626.80. The stock opened at ₹638.75, compared to its previous close of ₹637.45. During today's trading session, AKUMS DRUGS AND PHARMA L share price moved in the range of ₹621.00 to ₹645.00, with an average price of ₹633.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹409.30 and a high of ₹645.00. On the performance front, AKUMS DRUGS AND PHARMA L share price has increased by 38.72% over the last six months and is up 7.99% on a year-on-year basis.

₹621.00
1.67% down today
₹645.00
1D LOW
1D HIGH

AKUMS DRUGS AND PHARMA L Returns Calculator

Open
₹638.75
High
₹645.00
Low
₹621.00
Prev. close
₹637.45
Circuit
L
H
₹564.15
₹689.45
52-week
L
H
₹409.30
₹645.00

AKUMS DRUGS AND PHARMA L Shareholder Returns

AKUMS DRUGS AND PHARMA L Share Price History

Mkt Cap Cr
10,026.80
P/E
27.96
P/B
2.15
ROE
8.06%
D/E
0.02
ROCE
12.53%
Div. Yield
0.63%
EPS(TTM)
7.29
Turnover
0.54
EV/EBITDA
8.90
Net Margin
8.28%
Op. Margin
15.12%
ROA
5.78%
Quick Ratio
3.60
Curr. Ratio
3.26
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Akums Drugs outperforming all market indices
Step 2 of 5
Valuation
Expensive
Akums Drugs PE is significantly higher than its peers
Step 4 of 5
Earnings
Good
Akums Drugs revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

AKUMS DRUGS AND PHARMA L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹4,359.02₹4,118.16₹4,178.18₹3,654.82
Other Income₹128.73₹55.99₹34.03₹90.07
Total Revenue₹4,487.74₹4,174.15₹4,212.21₹3,744.89
Total Expenses₹4,085.62₹3,845.59₹4,231.45₹3,519.89
Profit Before Tax₹382.10₹345.25-₹45.28₹150.30
Tax₹125.70₹1.48-₹46.07₹52.48
Profit After Tax₹256.40₹343.78₹0.79₹97.82
EPS - Basic₹16.67₹22.60-₹0.28₹6.63
EPS - Diluted₹16.67₹22.60-₹0.28₹6.63

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹382.10₹345.25-₹45.28₹150.30
Income before WC changes₹546.36₹516.81₹510.81₹308.03
Change in Assets-₹205.31-₹65.66₹47.13₹9.25
Change in Liabilities₹927.52₹95.28₹2.74-₹43.58
Change in WC₹722.21₹29.62₹49.87-₹34.33
Cash flow from Operations₹1,181.20₹465.20₹498.26₹176.63
Cash flow from Investing-₹930.27-₹547.84-₹330.42-₹304.70
Cash flow from Financing₹33.88₹72.79-₹108.02₹124.54
Total Cash Flow₹284.81-₹9.86₹59.82-₹3.53
Cash (Start of the year)₹101.19₹111.05₹51.61₹55.14
Cash (End of the year)₹386.01₹101.19₹111.05₹51.61

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,887.11₹1,838.83₹1,575.48₹1,387.66
Current Assets₹3,559.86₹2,274.61₹1,940.88₹1,878.87
Total Assets₹5,446.97₹4,113.44₹3,516.37₹3,266.53
Current Liabilities₹1,094.76₹893.75₹1,210.55₹1,265.57
Net Current Asset₹2,465.10₹1,380.86₹730.33₹613.31
Non-Current Liabilities₹1,021.09₹156.08₹1,585.33₹1,277.59
Equity Capital₹3,331.12₹3,063.61₹720.49₹723.37
Total Equity & Liabilities₹5,446.97₹4,113.44₹3,516.37₹3,266.53

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,348.74₹1,311.78₹1,444.12₹1,286.83
Other Income₹112.97₹124.19₹94.12₹96.15
Total Revenue₹1,461.70₹1,435.98₹1,538.24₹1,382.98
Total Expenses₹1,306.82₹1,228.14₹1,621.78₹1,088.13
Profit Before Tax₹148.37₹207.84-₹102.93₹150.32
Tax₹36.73₹46.84₹62.52₹24.89
Profit After Tax₹111.64₹161.00-₹165.45₹125.43
EPS - Basic₹7.29₹10.76-₹11.56₹8.77
EPS - Diluted₹7.29₹10.76-₹11.56₹8.77

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹148.37₹207.84-₹102.93₹150.32
Income before WC changes₹111.21₹150.83₹241.07₹118.58
Change in Assets-₹86.41-₹24.94₹42.78₹23.14
Change in Liabilities₹8.90₹13.97₹0.35-₹106.13
Change in WC-₹77.51-₹10.96₹43.12-₹83.00
Cash flow from Operations-₹2.15₹91.00₹247.91₹94.01
Cash flow from Investing-₹24.97-₹458.84-₹165.44-₹202.17
Cash flow from Financing-₹3.00₹375.38-₹20.74₹89.90
Total Cash Flow-₹30.11₹7.54₹61.72-₹18.26
Cash (Start of the year)₹76.49₹68.96₹7.23₹25.49
Cash (End of the year)₹46.38₹76.49₹68.96₹7.23

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,488.98₹1,851.73₹1,562.18₹1,373.13
Current Assets₹1,323.50₹833.18₹533.24₹521.08
Total Assets₹2,812.48₹2,684.91₹2,095.43₹1,894.21
Current Liabilities₹304.00₹309.31₹501.74₹496.56
Net Current Asset₹1,019.50₹523.87₹31.50₹24.53
Non-Current Liabilities₹80.92₹70.36₹1,449.81₹1,086.15
Equity Capital₹2,427.57₹2,305.25₹143.88₹311.50
Total Equity & Liabilities₹2,812.48₹2,684.91₹2,095.43₹1,894.21
* All values are in INR Crore
Qty
Bid
38
626.8
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 38
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
64.59
Neutral
ATR (14)
19.53
Neutral
STOCH(9,6)
60.31
Neutral
STOCH RSI (14)
20.32
Bullish
ADX(9)
47.26
Bearish
UO(9)
34.96
Neutral
ROC(12)
5.02
Bullish
WillR(14)
-31.93
Neutral
Period
Simple value
Exponential vaue
5D
628.58
627.16
10D
620.69
619.92
20D
604.43
603.61
50D
562.18
568.97
100D
524.24
536

About AKUMS DRUGS AND PHARMA L

AKUMS DRUGS AND PHARMA L logo
ISIN
INE09XN01023
Sector Market Cap
₹ 10,026.8 Cr

Akums Drugs and Pharmaceuticals Limited is an India-based pharmaceutical contract development and manufacturing company. The Company offers a comprehensive range of pharmaceutical products and services in India and overseas. The Company’s segments include Contract Development and Manufacturing Operations (CDMO), Active Pharmaceutical Ingredient (API), Domestic Branded Formulations, International Branded Formulations, and Trade Generics. The CDMO segment is engaged in formulation research and development, preparation and regulatory filing of dossiers, manufacturing formulations on a contract basis, job work and testing services. The API segment is engaged in the manufacture and sale of key starting materials, Intermediate and API products. The Domestic Branded Formulations segment includes marketing of its branded formulations in the Indian market. The International Branded Formulations segment undertakes the marketing of its branded formulations in the global market.

AKUMS DRUGS AND PHARMA L Financial Highlights

  • Revenue: AKUMS DRUGS AND PHARMA L reported revenue of ₹4,487.75 crore in FY26 vs ₹4,170.28 crore in FY25. It showed an increase of 7.61% on a yearly basis.
  • Operating Profit: AKUMS DRUGS AND PHARMA L reported an operating profit of ₹382.10 crore in FY26 vs ₹345.25 crore in FY25. It showed an increase of 10.67% on a year-on-year basis.
  • Net Profit: AKUMS DRUGS AND PHARMA L reported a net profit of ₹256.40 crore in FY26 vs ₹343.78 crore in FY25. It showed a decrease of 25.42% on a yearly basis.

AKUMS DRUGS AND PHARMA L Quarterly Result Highlights

  • AKUMS DRUGS AND PHARMA L reported revenue of ₹1,193.17 crore in Mar 2026, compared with ₹1,193.92 crore in Dec 2025, representing a decrease of 0.06% on a quarter-on-quarter (QoQ) basis.
  • AKUMS DRUGS AND PHARMA L reported an operating profit of ₹121.22 crore in Mar 2026, compared with ₹99.57 crore in Dec 2025, representing an increase of 21.74% on a quarter-on-quarter (QoQ) basis.
  • AKUMS DRUGS AND PHARMA L reported a profit of ₹81.34 crore in Mar 2026, compared with ₹67.67 crore in Dec 2025, reflecting an increase of 20.20% on a QoQ basis.
  • The earnings per share (EPS) of AKUMS DRUGS AND PHARMA L stood at ₹16.67 during Mar 2026.
Know more
Promoters
75.26%
FII
1.37%
Other DII
3.40%
Retail and other
9.02%
Mutual funds
10.95%
Foreign institutions - FII
Compare against other stocks
AKUMS DRUGS AND PHARMA L logo
AKUMS DRUGS AND PHARMA L
Pharmaceuticals
Add Stock
Add Another

FAQs on AKUMS DRUGS AND PHARMA L Share Price